The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Immunogenicity Testing Service market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Immunogenicity Testing Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Immunogenicity Testing Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Immunogenicity Testing Service in Enterprise is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Immunogenicity Testing Service include Profacgen, Charles River Laboratories, Pacific BioLabs, Celerion, Precision Medicine Group, BioAgilytix, FyoniBio, Chimera Biotec and Alcyomics, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, A Single Assay, which accounted for % of the global market of Immunogenicity Testing Service in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immunogenicity Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunogenicity Testing Service.
The Immunogenicity Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Immunogenicity Testing Service market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunogenicity Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their
businesses. Some of the prominent players reviewed in the research report include:
- Profacgen
- Charles River Laboratories
- Pacific Biolabs
- Celerion
- Precision Medicine Group
- Bioagilytix
- Fyonibio
- Chimera Biotec
- Alcyomics
- Proimmune
- Creative Biolabs
- Sgs
- Eurofins Scientific
- Syrinx Bioanalytics
- Pharmaron
- Northeast Bioanalytical Laboratories
- Svar Life Science
- Cellcarta
- Biogenes
- Epivax
- Immunxperts
Product Type Insights
Global markets are presented by Immunogenicity Testing Service type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Immunogenicity Testing Service are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Immunogenicity Testing Service segment by Type
- A Single Assay
- Two Assays
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Immunogenicity Testing Service market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Immunogenicity Testing Service market.
Immunogenicity Testing Service Segment by Application
- Enterprise
- Factory
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Immunogenicity Testing Service market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunogenicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Immunogenicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Immunogenicity Testing Service industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunogenicity Testing Service.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunogenicity Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunogenicity Testing Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 A Single Assay
1.2.3 Two Assays
1.3 Market by Application
1.3.1 Global Immunogenicity Testing Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Enterprise
1.3.3 Factory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunogenicity Testing Service Market Perspective (2017-2028)
2.2 Immunogenicity Testing Service Growth Trends by Region
2.2.1 Immunogenicity Testing Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immunogenicity Testing Service Historic Market Size by Region (2017-2022)
2.2.3 Immunogenicity Testing Service Forecasted Market Size by Region (2023-2028)
2.3 Immunogenicity Testing Service Market Dynamics
2.3.1 Immunogenicity Testing Service Industry Trends
2.3.2 Immunogenicity Testing Service Market Drivers
2.3.3 Immunogenicity Testing Service Market Challenges
2.3.4 Immunogenicity Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunogenicity Testing Service Players by Revenue
3.1.1 Global Top Immunogenicity Testing Service Players by Revenue (2017-2022)
3.1.2 Global Immunogenicity Testing Service Revenue Market Share by Players (2017-2022)
3.2 Global Immunogenicity Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunogenicity Testing Service Revenue
3.4 Global Immunogenicity Testing Service Market Concentration Ratio
3.4.1 Global Immunogenicity Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunogenicity Testing Service Revenue in 2021
3.5 Immunogenicity Testing Service Key Players Head office and Area Served
3.6 Key Players Immunogenicity Testing Service Product Solution and Service
3.7 Date of Enter into Immunogenicity Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunogenicity Testing Service Breakdown Data by Type
4.1 Global Immunogenicity Testing Service Historic Market Size by Type (2017-2022)
4.2 Global Immunogenicity Testing Service Forecasted Market Size by Type (2023-2028)
5 Immunogenicity Testing Service Breakdown Data by Application
5.1 Global Immunogenicity Testing Service Historic Market Size by Application (2017-2022)
5.2 Global Immunogenicity Testing Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immunogenicity Testing Service Market Size (2017-2028)
6.2 North America Immunogenicity Testing Service Market Size by Country (2017-2022)
6.3 North America Immunogenicity Testing Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Immunogenicity Testing Service Market Size (2017-2028)
7.2 Europe Immunogenicity Testing Service Market Size by Country (2017-2022)
7.3 Europe Immunogenicity Testing Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunogenicity Testing Service Market Size (2017-2028)
8.2 Asia-Pacific Immunogenicity Testing Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Immunogenicity Testing Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Immunogenicity Testing Service Market Size (2017-2028)
9.2 Latin America Immunogenicity Testing Service Market Size by Country (2017-2022)
9.3 Latin America Immunogenicity Testing Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunogenicity Testing Service Market Size (2017-2028)
10.2 Middle East & Africa Immunogenicity Testing Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Immunogenicity Testing Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Profacgen
11.1.1 Profacgen Company Detail
11.1.2 Profacgen Business Overview
11.1.3 Profacgen Immunogenicity Testing Service Introduction
11.1.4 Profacgen Revenue in Immunogenicity Testing Service Business (2017-2022)
11.1.5 Profacgen Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Immunogenicity Testing Service Introduction
11.2.4 Charles River Laboratories Revenue in Immunogenicity Testing Service Business (2017-2022)
11.2.5 Charles River Laboratories Recent Development
11.3 Pacific BioLabs
11.3.1 Pacific BioLabs Company Detail
11.3.2 Pacific BioLabs Business Overview
11.3.3 Pacific BioLabs Immunogenicity Testing Service Introduction
11.3.4 Pacific BioLabs Revenue in Immunogenicity Testing Service Business (2017-2022)
11.3.5 Pacific BioLabs Recent Development
11.4 Celerion
11.4.1 Celerion Company Detail
11.4.2 Celerion Business Overview
11.4.3 Celerion Immunogenicity Testing Service Introduction
11.4.4 Celerion Revenue in Immunogenicity Testing Service Business (2017-2022)
11.4.5 Celerion Recent Development
11.5 Precision Medicine Group
11.5.1 Precision Medicine Group Company Detail
11.5.2 Precision Medicine Group Business Overview
11.5.3 Precision Medicine Group Immunogenicity Testing Service Introduction
11.5.4 Precision Medicine Group Revenue in Immunogenicity Testing Service Business (2017-2022)
11.5.5 Precision Medicine Group Recent Development
11.6 BioAgilytix
11.6.1 BioAgilytix Company Detail
11.6.2 BioAgilytix Business Overview
11.6.3 BioAgilytix Immunogenicity Testing Service Introduction
11.6.4 BioAgilytix Revenue in Immunogenicity Testing Service Business (2017-2022)
11.6.5 BioAgilytix Recent Development
11.7 FyoniBio
11.7.1 FyoniBio Company Detail
11.7.2 FyoniBio Business Overview
11.7.3 FyoniBio Immunogenicity Testing Service Introduction
11.7.4 FyoniBio Revenue in Immunogenicity Testing Service Business (2017-2022)
11.7.5 FyoniBio Recent Development
11.8 Chimera Biotec
11.8.1 Chimera Biotec Company Detail
11.8.2 Chimera Biotec Business Overview
11.8.3 Chimera Biotec Immunogenicity Testing Service Introduction
11.8.4 Chimera Biotec Revenue in Immunogenicity Testing Service Business (2017-2022)
11.8.5 Chimera Biotec Recent Development
11.9 Alcyomics
11.9.1 Alcyomics Company Detail
11.9.2 Alcyomics Business Overview
11.9.3 Alcyomics Immunogenicity Testing Service Introduction
11.9.4 Alcyomics Revenue in Immunogenicity Testing Service Business (2017-2022)
11.9.5 Alcyomics Recent Development
11.10 ProImmune
11.10.1 ProImmune Company Detail
11.10.2 ProImmune Business Overview
11.10.3 ProImmune Immunogenicity Testing Service Introduction
11.10.4 ProImmune Revenue in Immunogenicity Testing Service Business (2017-2022)
11.10.5 ProImmune Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Detail
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Immunogenicity Testing Service Introduction
11.11.4 Creative Biolabs Revenue in Immunogenicity Testing Service Business (2017-2022)
11.11.5 Creative Biolabs Recent Development
11.12 SGS
11.12.1 SGS Company Detail
11.12.2 SGS Business Overview
11.12.3 SGS Immunogenicity Testing Service Introduction
11.12.4 SGS Revenue in Immunogenicity Testing Service Business (2017-2022)
11.12.5 SGS Recent Development
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Detail
11.13.2 Eurofins Scientific Business Overview
11.13.3 Eurofins Scientific Immunogenicity Testing Service Introduction
11.13.4 Eurofins Scientific Revenue in Immunogenicity Testing Service Business (2017-2022)
11.13.5 Eurofins Scientific Recent Development
11.14 Syrinx Bioanalytics
11.14.1 Syrinx Bioanalytics Company Detail
11.14.2 Syrinx Bioanalytics Business Overview
11.14.3 Syrinx Bioanalytics Immunogenicity Testing Service Introduction
11.14.4 Syrinx Bioanalytics Revenue in Immunogenicity Testing Service Business (2017-2022)
11.14.5 Syrinx Bioanalytics Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Detail
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Immunogenicity Testing Service Introduction
11.15.4 Pharmaron Revenue in Immunogenicity Testing Service Business (2017-2022)
11.15.5 Pharmaron Recent Development
11.16 NorthEast BioAnalytical Laboratories
11.16.1 NorthEast BioAnalytical Laboratories Company Detail
11.16.2 NorthEast BioAnalytical Laboratories Business Overview
11.16.3 NorthEast BioAnalytical Laboratories Immunogenicity Testing Service Introduction
11.16.4 NorthEast BioAnalytical Laboratories Revenue in Immunogenicity Testing Service Business (2017-2022)
11.16.5 NorthEast BioAnalytical Laboratories Recent Development
11.17 Svar Life Science
11.17.1 Svar Life Science Company Detail
11.17.2 Svar Life Science Business Overview
11.17.3 Svar Life Science Immunogenicity Testing Service Introduction
11.17.4 Svar Life Science Revenue in Immunogenicity Testing Service Business (2017-2022)
11.17.5 Svar Life Science Recent Development
11.18 CellCarta
11.18.1 CellCarta Company Detail
11.18.2 CellCarta Business Overview
11.18.3 CellCarta Immunogenicity Testing Service Introduction
11.18.4 CellCarta Revenue in Immunogenicity Testing Service Business (2017-2022)
11.18.5 CellCarta Recent Development
11.19 BioGenes
11.19.1 BioGenes Company Detail
11.19.2 BioGenes Business Overview
11.19.3 BioGenes Immunogenicity Testing Service Introduction
11.19.4 BioGenes Revenue in Immunogenicity Testing Service Business (2017-2022)
11.19.5 BioGenes Recent Development
11.20 EpiVax
11.20.1 EpiVax Company Detail
11.20.2 EpiVax Business Overview
11.20.3 EpiVax Immunogenicity Testing Service Introduction
11.20.4 EpiVax Revenue in Immunogenicity Testing Service Business (2017-2022)
11.20.5 EpiVax Recent Development
11.21 ImmunXperts
11.21.1 ImmunXperts Company Detail
11.21.2 ImmunXperts Business Overview
11.21.3 ImmunXperts Immunogenicity Testing Service Introduction
11.21.4 ImmunXperts Revenue in Immunogenicity Testing Service Business (2017-2022)
11.21.5 ImmunXperts Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Immunogenicity Testing Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of A Single Assay
Table 3. Key Players of Two Assays
Table 4. Global Immunogenicity Testing Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Immunogenicity Testing Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Immunogenicity Testing Service Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Immunogenicity Testing Service Market Share by Region (2017-2022)
Table 8. Global Immunogenicity Testing Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Immunogenicity Testing Service Market Share by Region (2023-2028)
Table 10. Immunogenicity Testing Service Market Trends
Table 11. Immunogenicity Testing Service Market Drivers
Table 12. Immunogenicity Testing Service Market Challenges
Table 13. Immunogenicity Testing Service Market Restraints
Table 14. Global Immunogenicity Testing Service Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Immunogenicity Testing Service Market Share by Players (2017-2022)
Table 16. Global Top Immunogenicity Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunogenicity Testing Service as of 2021)
Table 17. Ranking of Global Top Immunogenicity Testing Service Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Immunogenicity Testing Service Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immunogenicity Testing Service Product Solution and Service
Table 21. Date of Enter into Immunogenicity Testing Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immunogenicity Testing Service Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Immunogenicity Testing Service Revenue Market Share by Type (2017-2022)
Table 25. Global Immunogenicity Testing Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Immunogenicity Testing Service Revenue Market Share by Type (2023-2028)
Table 27. Global Immunogenicity Testing Service Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Immunogenicity Testing Service Revenue Market Share by Application (2017-2022)
Table 29. Global Immunogenicity Testing Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Immunogenicity Testing Service Revenue Market Share by Application (2023-2028)
Table 31. North America Immunogenicity Testing Service Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Immunogenicity Testing Service Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Immunogenicity Testing Service Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Immunogenicity Testing Service Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Immunogenicity Testing Service Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Immunogenicity Testing Service Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Immunogenicity Testing Service Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Immunogenicity Testing Service Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Immunogenicity Testing Service Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Immunogenicity Testing Service Market Size by Country (2023-2028) & (US$ Million)
Table 41. Profacgen Company Detail
Table 42. Profacgen Business Overview
Table 43. Profacgen Immunogenicity Testing Service Product
Table 44. Profacgen Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 45. Profacgen Recent Development
Table 46. Charles River Laboratories Company Detail
Table 47. Charles River Laboratories Business Overview
Table 48. Charles River Laboratories Immunogenicity Testing Service Product
Table 49. Charles River Laboratories Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 50. Charles River Laboratories Recent Development
Table 51. Pacific BioLabs Company Detail
Table 52. Pacific BioLabs Business Overview
Table 53. Pacific BioLabs Immunogenicity Testing Service Product
Table 54. Pacific BioLabs Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 55. Pacific BioLabs Recent Development
Table 56. Celerion Company Detail
Table 57. Celerion Business Overview
Table 58. Celerion Immunogenicity Testing Service Product
Table 59. Celerion Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 60. Celerion Recent Development
Table 61. Precision Medicine Group Company Detail
Table 62. Precision Medicine Group Business Overview
Table 63. Precision Medicine Group Immunogenicity Testing Service Product
Table 64. Precision Medicine Group Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 65. Precision Medicine Group Recent Development
Table 66. BioAgilytix Company Detail
Table 67. BioAgilytix Business Overview
Table 68. BioAgilytix Immunogenicity Testing Service Product
Table 69. BioAgilytix Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 70. BioAgilytix Recent Development
Table 71. FyoniBio Company Detail
Table 72. FyoniBio Business Overview
Table 73. FyoniBio Immunogenicity Testing Service Product
Table 74. FyoniBio Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 75. FyoniBio Recent Development
Table 76. Chimera Biotec Company Detail
Table 77. Chimera Biotec Business Overview
Table 78. Chimera Biotec Immunogenicity Testing Service Product
Table 79. Chimera Biotec Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 80. Chimera Biotec Recent Development
Table 81. Alcyomics Company Detail
Table 82. Alcyomics Business Overview
Table 83. Alcyomics Immunogenicity Testing Service Product
Table 84. Alcyomics Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 85. Alcyomics Recent Development
Table 86. ProImmune Company Detail
Table 87. ProImmune Business Overview
Table 88. ProImmune Immunogenicity Testing Service Product
Table 89. ProImmune Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 90. ProImmune Recent Development
Table 91. Creative Biolabs Company Detail
Table 92. Creative Biolabs Business Overview
Table 93. Creative Biolabs Immunogenicity Testing ServiceProduct
Table 94. Creative Biolabs Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 95. Creative Biolabs Recent Development
Table 96. SGS Company Detail
Table 97. SGS Business Overview
Table 98. SGS Immunogenicity Testing ServiceProduct
Table 99. SGS Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 100. SGS Recent Development
Table 101. Eurofins Scientific Company Detail
Table 102. Eurofins Scientific Business Overview
Table 103. Eurofins Scientific Immunogenicity Testing ServiceProduct
Table 104. Eurofins Scientific Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 105. Eurofins Scientific Recent Development
Table 106. Syrinx Bioanalytics Company Detail
Table 107. Syrinx Bioanalytics Business Overview
Table 108. Syrinx Bioanalytics Immunogenicity Testing ServiceProduct
Table 109. Syrinx Bioanalytics Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 110. Syrinx Bioanalytics Recent Development
Table 111. Pharmaron Company Detail
Table 112. Pharmaron Business Overview
Table 113. Pharmaron Immunogenicity Testing ServiceProduct
Table 114. Pharmaron Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 115. Pharmaron Recent Development
Table 116. NorthEast BioAnalytical Laboratories Company Detail
Table 117. NorthEast BioAnalytical Laboratories Business Overview
Table 118. NorthEast BioAnalytical Laboratories Immunogenicity Testing ServiceProduct
Table 119. NorthEast BioAnalytical Laboratories Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 120. NorthEast BioAnalytical Laboratories Recent Development
Table 121. Svar Life Science Company Detail
Table 122. Svar Life Science Business Overview
Table 123. Svar Life Science Immunogenicity Testing ServiceProduct
Table 124. Svar Life Science Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 125. Svar Life Science Recent Development
Table 126. CellCarta Company Detail
Table 127. CellCarta Business Overview
Table 128. CellCarta Immunogenicity Testing ServiceProduct
Table 129. CellCarta Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 130. CellCarta Recent Development
Table 131. BioGenes Company Detail
Table 132. BioGenes Business Overview
Table 133. BioGenes Immunogenicity Testing ServiceProduct
Table 134. BioGenes Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 135. BioGenes Recent Development
Table 136. EpiVax Company Detail
Table 137. EpiVax Business Overview
Table 138. EpiVax Immunogenicity Testing ServiceProduct
Table 139. EpiVax Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 140. EpiVax Recent Development
Table 141. ImmunXperts Company Detail
Table 142. ImmunXperts Business Overview
Table 143. ImmunXperts Immunogenicity Testing ServiceProduct
Table 144. ImmunXperts Revenue in Immunogenicity Testing Service Business (2017-2022) & (US$ Million)
Table 145. ImmunXperts Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunogenicity Testing Service Market Share by Type: 2021 VS 2028
Figure 2. A Single Assay Features
Figure 3. Two Assays Features
Figure 4. Global Immunogenicity Testing Service Market Share by Application in 2021 & 2028
Figure 5. Enterprise Case Studies
Figure 6. Factory Case Studies
Figure 7. Immunogenicity Testing Service Report Years Considered
Figure 8. Global Immunogenicity Testing Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Immunogenicity Testing Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Immunogenicity Testing Service Market Share by Region: 2021 VS 2028
Figure 11. Global Immunogenicity Testing Service Market Share by Players in 2021
Figure 12. Global Top Immunogenicity Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunogenicity Testing Service as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Immunogenicity Testing Service Revenue in 2021
Figure 14. North America Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Immunogenicity Testing Service Market Share by Country (2017-2028)
Figure 16. United States Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Immunogenicity Testing Service Market Share by Country (2017-2028)
Figure 20. Germany Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Immunogenicity Testing Service Market Share by Region (2017-2028)
Figure 28. China Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Immunogenicity Testing Service Market Share by Country (2017-2028)
Figure 36. Mexico Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Immunogenicity Testing Service Market Share by Country (2017-2028)
Figure 40. Turkey Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Immunogenicity Testing Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Profacgen Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 43. Charles River Laboratories Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 44. Pacific BioLabs Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 45. Celerion Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 46. Precision Medicine Group Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 47. BioAgilytix Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 48. FyoniBio Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 49. Chimera Biotec Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 50. Alcyomics Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 51. ProImmune Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 52. Creative Biolabs Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 53. SGS Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 54. Eurofins Scientific Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 55. Syrinx Bioanalytics Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 56. Pharmaron Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 57. NorthEast BioAnalytical Laboratories Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 58. Svar Life Science Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 59. CellCarta Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 60. BioGenes Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 61. EpiVax Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 62. ImmunXperts Revenue Growth Rate in Immunogenicity Testing Service Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
